These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8166780)

  • 1. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?
    Oosting JD; Derksen RH; Bobbink IW; Hackeng TM; Bouma BN; de Groot PG
    Blood; 1993 May; 81(10):2618-25. PubMed ID: 8166780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.
    Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Iwatani Y; Kanakura Y
    Clin Chem; 2001 Jun; 47(6):1008-15. PubMed ID: 11375285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
    Pengo V; Biasiolo A; Brocco T; Tonetto S; Ruffatti A
    Thromb Haemost; 1996 May; 75(5):721-4. PubMed ID: 8725712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid.
    Rao LV; Hoang AD; Rapaport SI
    Blood; 1996 Dec; 88(11):4173-82. PubMed ID: 8943852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional effects of anticardiolipin antibodies.
    Harris EN; Pierangeli SS
    Lupus; 1996 Oct; 5(5):372-7. PubMed ID: 8902763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M; Finazzi G; Bevers EM; Barbui T
    Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein C.
    Galli M; Willems GM; Rosing J; Janssen RM; Govers-Riemslag JW; Comfurius P; Barbui T; Zwaal RF; Bevers EM
    Br J Haematol; 2005 Apr; 129(2):240-7. PubMed ID: 15813852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies: specificity and pathophysiology.
    de Groot PG; Oosting JD; Derksen RH
    Baillieres Clin Haematol; 1993 Sep; 6(3):691-709. PubMed ID: 8025348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells.
    Borrell M; Sala N; de Castellarnau C; Lopez S; Gari M; Fontcuberta J
    Thromb Haemost; 1992 Sep; 68(3):268-72. PubMed ID: 1440490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C.
    Galli M; Ruggeri L; Barbui T
    Blood; 1998 Mar; 91(6):1999-2004. PubMed ID: 9490682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies.
    Malia RG; Kitchen S; Greaves M; Preston FE
    Br J Haematol; 1990 Sep; 76(1):101-7. PubMed ID: 2145968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid syndrome: Reversal of antiphosphatidylserine/prothrombin-induced activated protein C resistance.
    Pontara E; Cattini MG; Bison E; Cheng C; Denas G; Pengo V
    Thromb Res; 2022 Oct; 218():17-23. PubMed ID: 35973396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C.
    Bakker HM; Tans G; Janssen-Claessen T; Thomassen MC; Hemker HC; Griffin JH; Rosing J
    Eur J Biochem; 1992 Aug; 208(1):171-8. PubMed ID: 1387359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus anticoagulants form immune complexes with prothrombin and phospholipid that can augment thrombin production in flow.
    Field SL; Hogg PJ; Daly EB; Dai YP; Murray B; Owens D; Chesterman CN
    Blood; 1999 Nov; 94(10):3421-31. PubMed ID: 10552952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin.
    Bevers EM; Galli M; Barbui T; Comfurius P; Zwaal RF
    Thromb Haemost; 1991 Dec; 66(6):629-32. PubMed ID: 1796407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.
    Gierula M; Salles-Crawley II; Santamaria S; Teraz-Orosz A; Crawley JTB; Lane DA; Ahnström J
    J Thromb Haemost; 2019 Dec; 17(12):2056-2068. PubMed ID: 31364267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In uremia, plasma levels of anti-protein C and anti-protein S antibodies are associated with thrombosis.
    Molino D; De Lucia D; Marotta R; Perna A; Lombardi C; Cirillo M; De Santo NG
    Kidney Int; 2005 Sep; 68(3):1223-9. PubMed ID: 16105054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity.
    Yang YH; Chang CJ; Chuang YH; Hsu HY; Chen PP; Chiang BL
    Rheumatology (Oxford); 2010 Jan; 49(1):34-42. PubMed ID: 19920091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.